The United States spends more on healthcare per capita than any other country on Earth. More than Switzerland. More than Germany. More than Norway. More than Canada. By a significant margin — roughly $12,500 per person per year, compared to an OECD average of about $6,000. The United States ranks 46th in life expectancy. These two numbers live in the same sentence so rarely that most Americans have never let them sit together. Sit with them now.

What the Spending Actually Buys

The instinct is to assume that the spending discrepancy reflects higher quality care — better technology, more specialists, faster access. For some Americans, in some circumstances, that is true. The U.S. produces a disproportionate share of medical research, cancer treatments, and surgical innovation. But when you break down where the money goes, the picture shifts. Administrative costs account for approximately 34% of U.S. healthcare expenditure — the highest of any developed country, and roughly double the administrative overhead in Canada's single-payer system. A 2019 study published in JAMA estimated that the U.S. spends around $800 billion annually on administrative complexity, including the costs of navigating thousands of distinct insurance plans, each with their own billing codes, preauthorization requirements, and coverage rules. Pharmaceutical prices in the U.S. are, on average, 2.5 times higher than in other wealthy nations for identical drugs — not because the drugs are different, but because the U.S. is one of the only developed countries that does not negotiate drug prices at a national level. Hospital list prices in the U.S. are set through a negotiation process between hospital systems and insurers that has no relationship to production costs. The Commonwealth Fund, which tracks healthcare system performance across 11 wealthy nations, found that the U.S. ranks last overall in healthcare system performance despite its spending — last in access, last in equity, and last in health outcomes, while ranking first in administrative efficiency costs. The spending is real. The outcomes are not commensurate.

A Tangent About Who Collects the Gap

The difference between what the U.S. spends and what peer nations spend — roughly $6,500 per person per year — flows somewhere. It does not evaporate. It flows to insurance company profits (the five largest U.S. health insurers collectively earned more than $35 billion in net profit in 2023). It flows to hospital system executive compensation (health system CEOs routinely earn $5-10 million annually). It flows to pharmaceutical company margins (industry average net profit margin of approximately 13-15%, among the highest of any sector). It flows to the administrative layer that employs 900,000 people whose primary function is managing billing complexity that does not exist in comparable healthcare systems. This is not accidental. Every provision of the U.S. healthcare system that maintains complexity, resists standardization, and prevents price negotiation has a constituency that benefits from it. The dysfunction is profitable — just not for patients.

What the Top-10 Countries Do Differently

The ten countries with the highest life expectancy in the world — Japan, Switzerland, South Korea, Australia, Spain, Singapore, Italy, Norway, Iceland, Israel — share certain structural features that the U.S. does not. Nearly all negotiate pharmaceutical prices nationally. Nearly all have universal or near-universal coverage that prevents catastrophic medical costs from falling entirely on individuals (medical debt is the leading cause of personal bankruptcy in the U.S. and is essentially nonexistent in other wealthy nations). Nearly all have primary care systems that emphasize prevention, with financial incentives aligned toward keeping populations healthy rather than treating illness. Japan, which ranks first globally in life expectancy, spends roughly $4,800 per capita. It has universal health insurance, negotiated drug prices, and a strong primary care infrastructure. Its system is not without flaws. But it produces better outcomes for less than 40% of what the U.S. spends.

Another Tangent: The Emergency Room Economy

The U.S. uses emergency rooms as the healthcare option of last resort for the uninsured and underinsured — a function that emergency rooms are structurally and economically unsuited for. Emergency care is the most expensive venue in the healthcare system per unit of care delivered. Using it as a substitute for primary care creates a cost pattern where a condition that could have been managed preventatively for hundreds of dollars becomes an emergency room visit costing thousands. The cost lands on the patient (often unpayable, generating medical debt), the hospital (which must provide emergency care regardless of ability to pay), and ultimately on the insured patients whose premiums absorb the uncompensated care costs. The system has no mechanism to prevent this. It was not designed to prevent it. It was designed to treat crises, not to prevent them — and crisis care is the most expensive care.

The Story These Numbers Tell

The 1st-in-spending and 46th-in-life-expectancy pairing is not a paradox. A paradox suggests something unexplainable. This is explained. The explanation is just uncomfortable. The U.S. spends more because it has not built the negotiating infrastructure and administrative simplicity that other nations use to control costs. Life expectancy is lower because cost control failures translate into access failures — people who cannot afford care, cannot afford medications, cannot afford prevention, who arrive at emergencies that could have been avoided. The spending is enormous. The benefits are captured by a small number of industries that have significant political influence. The costs — in both money and health — are distributed across 330 million people who have limited visibility into the mechanism. These two numbers sit in the same sentence now. The question is what you believe they require.